copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Cannabis Drug Reduces Drop Seizures in Severe Epilepsy Phase 3 data add rigorous evidence that a highly purified form of cannabidiol significantly reduces drop seizures in Lennox-Gastaut syndrome; FDA action expected in June
Pharma Grade CBD Effective in Lennox-Gastaut - Medscape Epidiolex, a purified oral form of cannabidiol, significantly reduced drop seizure frequency in patients with highly drug-resistant Lennox-Gastaut syndrome and could be available later this year
An Update on New Epilepsy Medications - Medscape Sirven emphasized that CBD is only indicated for three types of epilepsy: Dravet syndrome, Lennox-Gastaut syndrome, and drug-resistant epilepsy
Cannabidiol Reduces Drop Seizures in Lennox-Gastaut - Medscape Adding cannabidiol (CBD) to antiepileptic drug (AED) therapy significantly reduces the frequency of drop seizures in patients with Lennox-Gastaut syndrome (LGS), results of a phase 3 placebo
FDA Okays New Med for Lennox-Gastaut Syndrome - Medscape Already approved for Dravet syndrome, fenfluramine (Fintepla) for seizure control in LGS was supported by data from a global, randomized, placebo-controlled phase 3 clinical trial
DEA Reschedules Epidiolex, Paving the Way to Market - Medscape The US Drug Enforcement Administration has moved the FDA-approved cannabis-based drug for Lennox-Gastaut syndrome and Dravet syndrome from Schedule I to V, concluding that it has a low potential